Top Markets
Coin of the day
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Peringkat dalam Saham #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Harga Saham
$0.0001
Terakhir disinkronkan: 2026-07-02
Kapitalisasi Pasar
$2.20K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan Cotinga Pharmaceuticals Inc. (COTQF)

Kategori

Riwayat pemecahan saham untuk Cotinga Pharmaceuticals Inc. (COTQF)
Saham Cotinga Pharmaceuticals Inc. (simbol: COTQF) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 12, 2026.
Satu lembar saham COTQF yang dibeli sebelum Aug 12, 2026 sekarang setara dengan 0 lembar saham COTQF.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR